Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05244421 · ClinicalTrials.gov registry record · NA

SAY San Diego Dad Corps FIRE Program Evaluation

A NA study, sponsored by Midwest Evaluation & Research.

Completed
Registry status
NA
Development phase
444
Enrollment target

NCT05244421: Completed NA study, sponsored by Midwest Evaluation & Research.

NCT05244421 is a NA study that has completed, run by Midwest Evaluation & Research. The registered enrollment target is 444 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05244421, a NA study, has completed, sponsored by Midwest Evaluation & Research.

COMPLETED
Registry status
NA
Development phase
444 participants
Enrollment target

Study Summary

The purpose of the SAY San Diego Dad Corps FIRE program evaluation is to determine whether primary (i.e., behaviors) and secondary (i.e., attitudes) outcomes around parenting, co-parenting, employment, job readiness, and financial stability improve for participants after completing the SAY SDDC FIRE program.

Primary Outcome

Will participants report significantly healthier parenting behavior after completing primary educational services and employment support services? Items measured include: Parenting behavior and interaction with children measured with: 9 items- frequency of engagement in key behaviors (categories, 5-point scale) Measured on the Healthy Parenting Behavior Scale #1 as: 1=Never 2=1 to 2 days per month 3=3 or 4 days per month 4=2 or 3 days per week 5=Every day or almost every day Higher ratings

Interventions

  • OTHER Primary Services

Trial Details

FieldValue
Enrollment Target 444 participants
Start Date 2021-04-01
Est. Completion 2025-08-29
Phase NA
Midwest Evaluation & Research

12 total trials

What the finished NCT05244421 record still lists

NCT05244421 is an interventional study that assigns participants to a tested intervention. The registered 444 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 1 intervention - of which Primary Services is the first listed.

NCT05244421 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05244421 about?

NCT05244421 is a clinical study titled "SAY San Diego Dad Corps FIRE Program Evaluation". The purpose of the SAY San Diego Dad Corps FIRE program evaluation is to determine whether primary (i.e., behaviors) and secondary (i.e., attitudes) outcomes around parenting, co-parenting, employment, job readiness, and financial stability improve for participants after completing the SAY SDDC FIRE...

What is the current status of trial NCT05244421?

This trial is currently completed. It is a NA study. The enrollment target is 444 participants. The study started on 2021-04-01. Estimated completion is 2025-08-29.

What interventions are being tested in trial NCT05244421?

The interventions under investigation include: Primary Services (OTHER).

Who is sponsoring clinical trial NCT05244421?

This trial is sponsored by Midwest Evaluation & Research, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05244421's enrollment target sits among peer trials

444 233rd of 2000 higher than 1,768 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06348394 · 444 participants · NA

    Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion

  • NCT06700343 · 444 participants · Phase 3

    Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

  • NCT01280994 · 445 participants · Phase 2

    Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

  • NCT03504800 · 445 participants

    OCT in Diagnosis of Irregular Corneas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05244421, the US trial registry maintained by the National Library of Medicine. NCT05244421 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.